Free shipping on all orders over $ 500

CP 55940

Cat. No. M45339

All AbMole products are for research use only, cannot be used for human consumption.

CP 55940 Structure
Synonym:

CP-55,940

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

CP 55940 is a variant full agonist of the CB1 receptor that exhibits high and approximately equal affinity for central and peripheral cannabinoid receptors, with Ki's of 0.6 - 5.0 and 0.7-2.6 nM for CB1 and CB2, respectively, and EC50 values of 0.2 and 0.3 nM for CB1 and CB2, respectively.In addition, when acting on GRP55, the EC50 value is 5 nM.

Chemical Information
Molecular Weight 376.57
Formula C24H40O3
CAS Number 83003-12-7
Form Solid
Solubility (25°C) DMF 30 mg/mL
DMSO 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Avdesh Avdesh, et al. Psychopharmacology (Berl). Pharmacological effects of cannabinoids on the reference and working memory functions in mice

[2] S J Ward, et al. Behav Pharmacol. The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940)

[3] Suresh Sundram, et al. Naunyn Schmiedebergs Arch Pharmacol. Clozapine decreases [3H] CP 55940 binding to the cannabinoid 1 receptor in the rat nucleus accumbens

[4] Christy S Norwood, et al. Eur J Pharmacol. Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats

[5] B Dean, et al. Neuroscience. Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use

Related Cannabinoid Products
UCM707 

UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of Anandamide.

SCH 336

SCH 336 is a potent, selective, inverse and orally active CB2 agonist.

JTE-907 

JTE-907 is a highly selective, orally active CB2 receptor inverse agonist and exerts anti-inflammatory effects in vivo.

LEI-101 

LEI-101 is a potent, selective, and orally bioavailable cannabinoid CB2 receptor agonist, with a pEC50 of 8 for hCB2, and a pKi of less than 4 for hERG.

AEF0117 

AEF0117 is a signaling-specific inhibitor of the cannabinoid receptor 1 (CB1-SSi).

  Catalog
Abmole Inhibitor Catalog




Keywords: CP 55940, CP-55,940 supplier, Cannabinoid, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.